Vascular Endothelial Growth Factor and Severity of Nonproliferative Diabetic Retinopathy Mediate Retinal Hemodynamics In Vivo: A Potential Role for Vascular Endothelial Growth Factor in the Progression of Nonproliferative Diabetic Retinopathy-Reference-Cited by-同舟云学术

Vascular Endothelial Growth Factor and Severity of Nonproliferative Diabetic Retinopathy Mediate Retinal Hemodynamics In Vivo: A Potential Role for Vascular Endothelial Growth Factor in the Progression of Nonproliferative Diabetic Retinopathy

Published:1997-10 Issue:4 Volume:124 Page:433-446
ISSN:0002-9394
Container-title:American Journal of Ophthalmology
language:en
Short-container-title:American Journal of Ophthalmology

Author:

CLERMONT ALLEN C.,AIELLO LLOYD PAUL,MORI FUMIHIKO,AIELLO LLOYD M.,BURSELL SVEN-ERIK

Publisher

Elsevier BV

Subject

Ophthalmology

Reference64 articles.

1. Ocular complications of diabetes mellitus;Aiello,1994

2. Hypoxic regulation of vascular endothelial growth factor in retinal cells;Aiello;Arch Ophthalmol,1995

3. Detection of vascular endothelial growth factor messenger RNA and vascular endothelial growth factor-like activity in proliferative diabetic retinopathy;Malecaze;Arch Ophthalmol,1994

4. Vascular endothelial growth factor plays a role in hyperpermeability of diabetic retinal vessels;Murata;Ophthalmic Res,1995

5. The retinal blood flow in diabetes;Kohner;Diabetologia,1975

Cited by 149 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Quantitative evaluation of ocular vascularity and correlation analysis in patients with diabetic retinopathy by SMI and OCTA;BMC Ophthalmology;2024-02-19

2. Diabetic retinopathy, a neurovascular unit disease;Therapeutic Targets for Diabetic Retinopathy;2024

3. Effects of Intravitreal Ranibizumab Injection on Peripheral Retinal Microcirculation and Cytokines in Branch Retinal Vein Occlusion with Macular Edema;Medicina;2023-05-30

4. Retinal Ischaemia in Diabetic Retinopathy: Understanding and Overcoming a Therapeutic Challenge;Journal of Clinical Medicine;2023-03-21

5. Oral administration of CU06-1004 attenuates vascular permeability and stabilizes neovascularization in retinal vascular diseases;European Journal of Pharmacology;2023-01